期刊文献+

结外侵犯非霍奇金淋巴瘤224例的临床病理特征及疗效分析 被引量:4

Clinicopathologic characteristics and treatment response of 224 cases of non-Hodgkin lymphoma with extranodal involvement
暂未订购
导出
摘要 目的:探讨初治时伴结外侵犯的非霍奇金淋巴瘤(non-Hodgkins lymphoma,NHL)的临床病理特征及其与疗效的关系。方法:回顾性分析初治伴结外侵犯的NHL患者224例,分析其临床病理特征,采用χ2检验,比较不同临床特征与完全缓解率之间的关系。结果:224例伴结外侵犯的患者中B细胞NHL140例,主要为弥漫大B细胞淋巴瘤(77例);T细胞NHL84例,主要为外周T细胞淋巴瘤非特指型(53例)。伴结外侵犯的B细胞NHL,最常见的侵犯部位是咽淋巴环、胃肠道和浆膜腔;伴结外侵犯的T细胞NHL,最常见的侵犯部位是咽淋巴环和鼻腔副鼻窦。B细胞NHL完全缓解率为34.3%(48例),T细胞NHL完全缓解率为31.0%(26例)。Ⅲ~Ⅳ期、B症状、体能状况差、巨大包块者完全缓解率低;性别、LDH及是否放疗与完全缓解率无相关性,P>0.05;国际预后指数(IPI)不同的患者,其完全缓解率差异有统计学意义(B细胞性淋巴瘤P=0.023,T细胞性淋巴瘤P=0.014)。结论:伴结外侵犯的NHL最常见的病理类型是弥漫大B细胞淋巴瘤和外周T细胞淋巴瘤非特指型,其完全缓解率低,可以利用IPI指数预测其疗效与预后。 OBJECTIVE: To retrospectively analyze the clinicopathologic characteristics and treatment response of 224 cases of non-Hodgkin lymphoma (NHL) with extranodal involvement and explore the association between the clinical characteristics and prognosis. METHODS: A total of 224 cases of lymphoma with extranodal involvement treated in Guangxi cancer hospital were retrospectively analyzed, and the association between the clinical factors and the probability of attaining complete remission (CR) was evaluated by Chi-square test. RESULTS: Among 224 cases, 140 cases were B cell NHL, and the most common pathological type was diffuse large B cell lymphoma (77), the most frequent extranodal involvement sites were waldeyer's ring, gastrointestinal tract and serous cavity; 84 cases were T cell NHL, and the most common pathological type was peripheral T cell lymphoma-unspecified (53), the most frequent extranodal involvement sites were waldeyer's ring and nasal cavity. The CR rates were 34.3% (48) in B cell NHL and 31. 0%(26) in T cell NHL, and the factors associated with a lower probability of achieving CR were advanced disease (stage Ⅲ-Ⅳ ), poor PS, bulky disease. LDH levels, gender and radiotherapy were not significantly associated with CR rate. The patients with different IPI significantly showed various CR rates ( P values were 0. 023 in B cell lymphoma and 0. 014 in T cell lymphoma, respectively). CONCLUSIONS: The most common subgroups of NHL with extranodal involvement are diffuse large B cell lymphoma and peripheral T cell lymphomaunspecified, and there is a low CR rate in these cases. IPI is proved to be of highly significant prognostic value.
出处 《中华肿瘤防治杂志》 CAS 2007年第22期1721-1724,共4页 Chinese Journal of Cancer Prevention and Treatment
关键词 淋巴瘤 非霍奇金 结外侵犯 临床特征 预后 lymphorna, non-Hodgkin extranodal involvement clinical characteristics prognosis
  • 相关文献

参考文献8

二级参考文献28

  • 1陆林,胡宗涛.吉西他滨联合奥沙利铂治疗老年晚期非小细胞肺癌观察[J].肿瘤防治杂志,2005,12(18):1415-1416. 被引量:2
  • 2Kim K,Kim WS,Jung LW,et al.Clinical features of peripheral T-cell lymphomas in 78patients diagnosed according to the REAL classification[J].Eur J Cancer,2002,38(1):75-81.
  • 3Edward R,Arrowsmit H,William R,et al.Peripheral T-cell Lymphomas:Clinical Features and Prognostic Factors of 92 Cases Defined by the Revised European American Lymphoma Classification[J].Leukemia Lymphoma,2003,44(2):241-249.
  • 4Gallamini A,Stelitano C,Calvi R,et al.Peripheral T-cell lymphoma unspecified(PTCL-U):a new prognostic model from a retrospective multicentric clinical study[J].Blood,2004,103(7):2474-2479.
  • 5Rudiger T,Weisenburger DD,Anderson JR,et al.Peripheral T-cell lymphoma(excluding anaplastic large-cell lymphoma):results from the Non-Hodgkin's Lymphoma classification project[J].Ann Oncol,2002,13(1):140-149.
  • 6Harris NL,Jaffe ES,Stein H,et al.A revised European-American classfication of Lmphoid neoplasms:a proposal from the international lymphoma study group[J].Blood,1994,84(5):1361-1392.
  • 7Lopez-Guillermo A,Cid J,Salar A,et al.Peripheral T-cell lymphoma:initial features,natural history,and prognostic factors in a series of 174 patients diagnosed according to the REAL Classification[J].Ann Oncol,1998,9(8):849-855.
  • 8Zaja F,Russo D,et al.Retrospective analysis of 23 cases with peripheral T-cell lymphoma,unspecified:clinical characteristics and outcome[J].Hematologica,1997,82(2):171-177.
  • 9Lee HK,Wilder RB,Jones D,et al.Outcomes using doxorubicin-based chemotherapy with or without radiotherapy for early-stage peripheral T-cell lymphomas[J].Leu Lymphoma,2002,43(9):1769-1775.
  • 10Pellatt J,Sweetenham J,Pickering RM,et al.A single-centre study of treatment outcomes and survival in 120 patients with peripheral T-cell non-Hodgkin's lymphoma[J].Ann Hematol,2002,81(5):267-72.

共引文献63

同被引文献19

  • 1熊强,徐华,黄平.原发性结外淋巴瘤132例分析[J].赣南医学院学报,2005,25(5):648-649. 被引量:7
  • 2周建军,丁建国,周康荣,王建华,曾蒙苏,程伟中.结外淋巴瘤:影像学共性特征与病理的关系[J].临床放射学杂志,2007,26(6):618-622. 被引量:78
  • 3Chan J K. The new World Health Organization Classification of lymphomas: The past, the present and the future[J]. Hematol Oncol, 2001. 19:129-150.
  • 4Anon. A clinical evaluation of the international lymphoma study group classification of non hodgkin' s lymphgoma. The nonhodgkin' s lymphoma classification project[J]. Blood, 1997, 89 : 3909-3918.
  • 5Hall P A, Richards M A, Gregoty W M, et al. The prognostic value of Ki-67 immunostaining in non Hodgkin's lymphoma[J]. J Pathol, 1998,154= 223-225.
  • 6Schmitt F, Tani E, Tribukait B, et al. Assessment of cell proliferation by Ki-67 staining and flow cytometry in fine needle as pirates(FNAs) of reactive lymphadenitis and non Hodgkin's lyre phoma[J]. Cytopathology, 1999, 10:87-96.
  • 7Ilica AT,Kocacelebi K,Savas R,et al. Imaging of extranodal lym- phoma with PET/CT[J]. Clin Nucl Med, 2011,36 (10): e127 e138.
  • 8Schaefer NG, Hany TF, Taverna C, et al. Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging-do we need contrast- enhanced CT? [J]. Radiology, 2004,232(3) :823-829.
  • 9Schae{er NG,Strobel K,Taverna C,et al. Bone involvement in pa- tients with lymphoma= the role of FDG-PET/CT[J]. Eur J Nucl Med Mol Imaging,2007,34(1) :60- 67.
  • 10Pakos EE,Fotopoulos AD,Ioannidis JP,et al. 18F-FDG PET for e- valuation of bone marrow infiltration in staging of lymphoma= a meta-analysis[J]. J Nucl Med,2005,46(6) :958-963.

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部